AP

AMPCO-PITTSBURGH CORP: 10-Q Summary (Q2 2026)

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2026. Ampco-Pittsburgh Corporation manufactures high-performance specialty metal products and customized equipment through two segments: Forged and Cast Engineered Products (FCEP) and Air and Liquid Processing (ALP). The company is a non-accelerated filer and smaller reporting company. As of August 6, 2026, 20,658,621 common shares were outstanding.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue: Total net sales decreased 9.0% year-over-year for the quarter and 2.8% for the six-month period. The FCEP segment saw a significant decline due to the insolvency of its UK subsidiary (UES-UK) and lower volume of large roll shipments. The ALP segment saw a slight increase driven by power generation and defense demand.
• Profitability: Operating income improved significantly compared to the prior year, turning from a loss of $3.1 million to a profit of $5.1 million for the quarter. This improvement is largely due to the absence of a $6.8 million "U.K. Exit Charge" recorded in Q2 2025.
• Unusual Items:
  • Deconsolidation Charge: A non-cash charge of $0.9 million was recorded in the first half of 2026 related to the write-down of the estimated recovery from the UES-UK insolvency.
  • Severance: The prior year included a $5.9 million severance charge related to UES-UK, which did not recur in 2026.
• Liquidity: Cash and cash equivalents decreased by $3.7 million during the six-month period, primarily due to increased capital expenditures ($9.1 million) and working capital investments (inventory buildup).

Guidance, Outlook, and Risks

• Outlook: Management expects the FCEP segment to benefit from U.S. tariffs on steel imports, which are supporting pricing and mill utilization. The ALP segment is investing in capacity to meet growing demand in data center power generation and defense sectors.
• Backlog: Total backlog increased to $385.4 million, up $56.4 million from year-end 2025. Approximately 44% of the backlog is expected to ship after 2026.
• Asbestos Litigation: The company faces ongoing asbestos liability. As of June 30, 2026, there were 2,954 active claims. The recorded asbestos liability is $185.0 million, with an insurance receivable of $117.0 million. Management notes that actual expenses could vary significantly based on litigation outcomes and insurance carrier solvency.
• Debt Covenants: The company remains in compliance with its revolving credit facility covenants, which require a minimum Fixed Charge Coverage Ratio of 1.05 to 1.00 or maintenance of excess availability.

Investor Verification Checklist

• UES-UK Recovery: Verify the collectability of the remaining $5.4 million "Estimated Recovery" asset from the UK insolvency, as further write-downs could impact earnings.
• Asbestos Reserve Adequacy: Review the assumptions regarding insurance recoveries and claim settlement costs, given the volatility in the number of active claims and potential carrier insolvencies.
• Working Capital Trends: Monitor the increase in inventory ($113.8 million) and trade receivables ($86.4 million) to ensure they align with the reported backlog and do not signal collection or obsolescence issues.
• Capital Expenditures: Confirm the timing and ROI of the $9.1 million in capital expenditures, particularly the new equipment in the ALP segment expected to commission in late 2026.
• Valuation Allowance: Assess the likelihood of releasing the valuation allowance on deferred tax assets, which could provide a future tax benefit if profitability in Sweden and the U.S. sustains.